Arsenic induced progesterone production in a caspase-3-dependent manner and changed redox status in preovulatory granulosa cells

Journal of Cellular Physiology

Volumn 227, Issue 1, 2012, Pages 194-203

  Yuan, Xiao Hua ^a,b,c   Lu, Cai Ling ^b,c   Yao, Nan ^a,b,c   An, Li Sha ^a,b,c   Yang, Bai Qing ^a,b,c   Zhang, Chuan Ling ^a,b,c   Ma, Xu ^a,b,c  

^a GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^b NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; BUTHIONINE SULFOXIMINE; CASPASE 3; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FOLLITROPIN; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROGESTERONE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; FEMALE; GRANULOSA CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PREOVULATOY GRANULOSA CELL; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROGESTERONE RELEASE; PROTEIN PHOSPHORYLATION; RAT; SPRAGUE DAWLEY RAT; STEROIDOGENESIS;

ANIMALS; ARSENITES; BLOTTING, WESTERN; CASPASE 3; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; GLUTATHIONE; GRANULOSA CELLS; LUMINESCENT MEASUREMENTS; MEMBRANE POTENTIAL, MITOCHONDRIAL; OXIDATION-REDUCTION; PROGESTERONE; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TERATOGENS; TRANSFECTION;

RATTUS;

EID: 80054948470     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22717     Document Type: Article

References (58)

1. Abernathy CO, Thomas DJ, Calderon RL. 2003. Health effects and risk assessment of arsenic. J Nutr 133:1536S-1538S.
2. Akram Z, Jalali S, et al. 2009. Adverse effects of arsenic exposure on uterine function and structure in female rat. Exp Toxicol Pathol 62:451-459.
3. Amsterdam A, Selvaraj N. 1997. Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes. Endocr Rev 18:435-461.
4. Behera MA, Dai Q, et al. 2009. Progesterone stimulates mitochondrial activity with subsequent inhibition of apoptosis in MCF-10A benign breast epithelial cells. Am J Physiol Endocrinol Metab 297:E1089-E1096.
5. Bernstam L, Nriagu J. 2000. Molecular aspects of arsenic stress. J Toxicol Environ Health B Crit Rev 3:293-322.
6. Bode AM, Dong Z. 2002. The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Crit Rev Oncol Hematol 42:5-24.
7. Bodwell JE, Kingsley LA, et al. 2004. Arsenic at very low concentrations alters glucocorticoid receptor (GR)-mediated gene activation but not GR-mediated gene repression: Complex dose-response effects are closely correlated with levels of activated GR and require a functional GR DNA binding domain. Chem Res Toxicol 17:1064-1076.
8. Boyer A, Goff AK, et al. 2010. WNT signaling in ovarian follicle biology and tumorigenesis. Trends Endocrinol Metab 21:25-32.
9. Catt KJ, Harwood JP, et al. 1980. Regulation of peptide hormone receptors and gonadal steroidogenesis. Recent Prog Horm Res 36:557-662.
10. Chang SI, Jin B, et al. 2007. Arsenic-induced toxicity and the protective role of ascorbic acid in mouse testis. Toxicol Appl Pharmacol 218:196-203.
11. Chattopadhyay S, Ghosh D. 2010. The involvement of hypophyseal-gonadal and hypophyseal-adrenal axes in arsenic-mediated ovarian and uterine toxicity: Modulation by hCG. J Biochem Mol Toxicol 24:29-41.
12. Chattopadhyay S, Ghosh S, et al. 1999. Effect of sodium arsenite on plasma levels of gonadotrophins and ovarian steroidogenesis in mature albino rats: Duration-dependent response. J Toxicol Sci 24:425-431.
13. Chen H, Pechenino AS, et al. 2008. Effect of glutathione depletion on Leydig cell steroidogenesis in young and old brown Norway rats. Endocrinology 149:2612-2619.
14. Chen H, Zhou L, et al. 2010. Effect of glutathione redox state on Leydig cell susceptibility to acute oxidative stress. Mol Cell Endocrinol 323:147-154.
15. Chowdhury R, Chowdhury S, et al. 2010. Arsenic induced apoptosis in malignant melanoma cells is enhanced by menadione through ROS generation, p38 signaling and p53 activation. Apoptosis 14:108-123.
16. Cooke BA. 1999. Signal transduction involving cyclic AMP-dependent and cyclic AMP-independent mechanisms in the control of steroidogenesis. Mol Cell Endocrinol 151:25-35.
17. Davey JC, Bodwell JE, et al. 2007. Arsenic as an endocrine disruptor: Effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture. Toxicol Sci 98:75-86.
18. Davey JC, Nomikos AP, et al. 2008. Arsenic as an endocrine disruptor: Arsenic disrupts retinoic acid receptor- and thyroid hormone receptor-mediated gene regulation and thyroid hormone-mediated amphibian tail metamorphosis. Environ Health Perspect 116:165-172.
19. De Vizcaya-Ruiz A, Barbier O, et al. 2009. Biomarkers of oxidative stress and damage in human populations exposed to arsenic. Mutat Res 674:85-92.
20. Desagher S, Martinou JC. 2000. Mitochondria as the central control point of apoptosis. Trends Cell Biol 10:369-377.
21. Diemer T, Allen JA, et al. 2003. Reactive oxygen disrupts mitochondria in MA-10 tumor Leydig cells and inhibits steroidogenic acute regulatory (StAR) protein and steroidogenesis. Endocrinology 144:2882-2891.
22. Fernando P, Kelly JF, et al. 2002. Caspase 3 activity is required for skeletal muscle differentiation. Proc Natl Acad Sci USA 99:11025-11030.
23. Ghibelli L, Fanelli C, et al. 1998. Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J 12:479-486.
24. Guo XJ, Ma H.z., et al. 1994. The chronic impact of arsenic on genitourinary system. Prev Cure Endem Dis Inn Mongolia 19:86-87.
25. Hales DB, Allen JA, et al. 2005. Mitochondrial function in Leydig cell steroidogenesis. Ann NY Acad Sci 1061:120-134.
26. Hoang YD, Nakamura BN, et al. 2009. Follicle-stimulating hormone and estradiol interact to stimulate glutathione synthesis in rat ovarian follicles and granulosa cells. Biol Reprod 81:636-646.
27. Hunzicker-Dunn M, Maizels ET. 2006. FSH signaling pathways in immature granulosa cells that regulate target gene expression: Branching out from protein kinase A. Cell Signal 18:1351-1359.
28. Ishizaki Y, Jacobson MD, et al. 1998. A role for caspases in lens fiber differentiation. J Cell Biol 140:153-158.
29. Jana K, Jana S, et al. 2006. Effects of chronic exposure to sodium arsenite on hypothalamo-pituitary-testicular activities in adult rats: Possible an estrogenic mode of action. Reprod Biol Endocrinol 4:9.
30. Kaltreider RC, Davis AM, et al. 2001. Arsenic alters the function of the glucocorticoid receptor as a transcription factor. Environ Health Perspect 109:245-251.
31. Kuranaga E, Miura M. 2007. Nonapoptotic functions of caspases: Caspases as regulatory molecules for immunity and cell-fate determination. Trends Cell Biol 17:135-144.
32. Lamkanfi M, Festjens N, et al. 2007. Caspases in cell survival, proliferation and differentiation. Cell Death Differ 14:44-55.
33. Luderer U, Kavanagh TJ, et al. 2001. Gonadotropin regulation of glutathione synthesis in the rat ovary. Reprod Toxicol 15:495-504.
34. Maiti S, Chatterjee AK. 2001. Effects on levels of glutathione and some related enzymes in tissues after an acute arsenic exposure in rats and their relationship to dietary protein deficiency. Arch Toxicol 75:531-537.
35. Manna PR, Chandrala SP, et al. 2006. cAMP-independent signaling regulates steroidogenesis in mouse Leydig cells in the absence of StAR phosphorylation. J Mol Endocrinol 37:81-95.
36. Nayak S, Shen M, et al. 2010. Arsenic trioxide cooperates with all trans retinoic acid to enhance mitogen-activated protein kinase activation and differentiation in PML-RARalpha negative human myeloblastic leukemia cells. Leuk Lymphoma 51:1734-1747.
37. Nicholson DW, Ali A, et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43.
38. Niswender GD. 2002. Molecular control of luteal secretion of progesterone. Reproduction 123:333-339.
39. Noh EK, Kim H, et al. 2010. Gefitinib enhances arsenic trioxide (AS(2)O(3))-induced differentiation of acute promyelocytic leukemia cell line. Leuk Res 34:1501-1505.
40. Okuyama R, Nguyen BC, et al. 2004. High commitment of embryonic keratinocytes to terminal differentiation through a Notch1-caspase 3 regulatory mechanism. Dev Cell 6:551-562.
41. Oomman S, Strahlendorf H, et al. 2006. Bergmann glia utilize active caspase-3 for differentiation. Brain Res 1078:19-34.
42. Peluso JJ, Pappalardo A. 2004. Progesterone regulates granulosa cell viability through a protein kinase G-dependent mechanism that may involve 14-3-3sigma. Biol Reprod 71:1870-1878.
43. Ramanathan K, Shila S, et al. 2003. Protective role of ascorbic acid and alpha-tocopherol on arsenic-induced microsomal dysfunctions. Hum Exp Toxicol 22:129-136.
44. Santra A, Maiti A, et al. 2000. Hepatic damage caused by chronic arsenic toxicity in experimental animals. J Toxicol Clin Toxicol 38:395-405.
45. Schmidt AJ, Krieg JC, et al. 2002. Differential effects of glucocorticoids and gonadal steroids on glutathione levels in neuronal and glial cell systems. J Neurosci Res 67:544-550.
46. Seger R, Hanoch T, et al. 2001. The ERK signaling cascade inhibits gonadotropin-stimulated steroidogenesis. J Biol Chem 276:13957-13964.
47. Smith KR, Klei LR, et al. 2001. Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 280:L442-L449.
48. Snow ET, Sykora P, et al. 2005. Arsenic, mode of action at biologically plausible low doses: What are the implications for low dose cancer risk? Toxicol Appl Pharmacol 207:557-564.
49. Sordet O, Rebe C, et al. 2002. Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood 100:4446-4453.
50. Stocco DM. 2000. The role of the StAR protein in steroidogenesis: Challenges for the future. J Endocrinol 164:247-253.
51. Stocco DM, Wang X, et al. 2005. Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: More complicated than we thought. Mol Endocrinol 19:2647-2659.
52. Strauss JF III, Kallen CB, et al. 1999. The steroidogenic acute regulatory protein (StAR): A window into the complexities of intracellular cholesterol trafficking. Recent Prog Horm Res 54:369-394, discussion 394-365.
53. Svechnikov K, Soder O. 2008. Ontogeny of gonadal sex steroids. Best Pract Res Clin Endocrinol Metab 22:95-106.
54. Terranova PF, Garza F. 1983. Relationship between the preovulatory luteinizing hormone (LH) surge and androstenedione synthesis of preantral follicles in the cyclic hamster: Detection by in vitro responses to LH. Biol Reprod 29:630-636.
55. Tsai-Turton M, Luderer U. 2006. Opposing effects of glutathione depletion and follicle-stimulating hormone on reactive oxygen species and apoptosis in cultured preovulatory rat follicles. Endocrinology 147:1224-1236.
56. Yacobi K, Wojtowicz A, et al. 2004. Gonadotropins enhance caspase-3 and -7 activity and apoptosis in the theca-interstitial cells of rat preovulatory follicles in culture. Endocrinology 145:1943-1951.
57. Yacobi K, Tsafriri A, et al. 2007. Luteinizing hormone-induced caspase activation in rat preovulatory follicles is coupled to mitochondrial steroidogenesis. Endocrinology 148:1717-1726.
58. Yu FQ, Han CS, et al. 2005. Role of ERK1/2 in FSH induced PCNA expression and steroidogenesis in granulosa cells. Front Biosci 10:896-904.